• Acetylspiramycin Workflow for Resistance Research

  2026-08-20

  Acetylspiramycin (Spiramycin B) supports controlled ribosomal inhibition studies, broth microdilution susceptibility testing, and resistance-mechanism profiling. Its value extends beyond MIC measurement when formulation, solvent controls, orthogonal readouts, and host-response variables are managed together.

• Firefly Luciferase mRNA: Mechanism and Workflow

  2026-08-20

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) is a modified in vitro transcribed reporter for transient protein expression. Its defined cap, nucleotide chemistry, poly(A) tail, and storage formulation support reproducible gene expression, cell viability, and imaging workflows when delivery and substrate conditions are controlled.

• ML-7 Hydrochloride in Cardiac I/R Research

  2026-08-19

  ML-7 hydrochloride provides a practical way to connect MLCK-dependent myosin light-chain phosphorylation with cardiac contractility, cardiomyocyte death, and endothelial barrier behavior. This workflow-focused guide shows how to plan dose-finding, pair pathway readouts with annexin-V detection, and troubleshoot solubility, timing, and interpretation issues.

• Protease Inhibitor Cocktail: EDTA-Free Workflow Guide

  2026-08-19

  Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during protein extraction and sample preparation. It is suited to lysates and protein workflows where EDTA could interfere with divalent-cation-dependent assays, but it should not be treated as a universal substitute for rapid handling, cold-chain control, or assay-specific compatibility testing.

• Bifidobacterium, FMT, and Neuroinflammation in HE

  2026-08-18

  This study used [18F]PBR146 micro-PET/CT to compare Bifidobacterium and fecal microbiota transplantation in bile duct ligation rats with chronic hepatic encephalopathy. Regional, rather than whole-brain, imaging differences suggested that Bifidobacterium reduced neuroinflammatory activity, while behavioral, cytokine, and global uptake results did not show broad treatment effects.

• HotStart 2X Green qPCR Master Mix for dAGE Studies

  2026-08-18

  Translate metabolic mouse findings into a focused SYBR Green workflow for validating AMPK–PGC1α, lipid, glucose, and thermogenesis genes. The hot-start format helps reduce nonspecific amplification while preserving a practical, scalable path from tissue RNA to quantitative results.

• Paroxetine: Molecular Mechanisms Beyond SERT

  2026-08-17

  Kowalska and colleagues provide a molecularly focused review of paroxetine that extends beyond its canonical role as a Selective serotonin reuptake inhibitor. The paper integrates evidence on monoamine transporters, CYP2D6, GRK2, and viral glycoprotein interactions, offering a framework for interpreting both therapeutic activity and concentration-dependent off-target effects.

• Carrier-Free Paclitaxel Nanoparticles for TNBC

  2026-08-17

  A 2024 ACS Applied Nano Materials study developed high-loading, carrier-free nanoparticles by coassembling Paclitaxel and gambogic acid, then coating the drug core with folate-functionalized human serum albumin. The resulting formulation combined coordinated delivery of two anticancer agents with folate receptor targeting and showed improved tumor localization in a triple-negative breast cancer model.

• Protease Inhibitor Cocktail for TCR Assays

  2026-08-16

  Learn how a Protease Inhibitor Cocktail EDTA-Free can preserve receptor complexes, phosphorylation states, and assay interpretability in LAG-3/TCR research. This guide translates a recent proximity-based immunology study into practical protein-preparation decisions.

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus

  2026-08-15

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus is designed for in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based assays. It is intended for research workflows such as in situ hybridization and Northern blot hybridization, not for diagnostic, therapeutic, or clinical use.

• How p38α Dephosphorylation Changes Kinase Inhibition

  2026-08-14

  The reference preprint shows that some kinase inhibitors can do more than occupy the p38α active site: they can stabilize an activation-loop conformation that accelerates WIP1-mediated dephosphorylation. This dual-action mechanism provides a structural framework for improving kinase inhibitor potency and specificity, while remaining distinct from evidence in cellular cytokine assays or disease models.

• TNF-alpha Recombinant Murine Protein in Cell-Death Mapping

  2026-08-14

  Explore how TNF-alpha recombinant murine protein can anchor reproducible apoptosis and inflammation assays while serving as a mechanistically distinct comparator for RNA Pol II degradation-dependent cell death. This guide connects product specifications with experimental design, pathway interpretation, and assay quality control.

• LTI6426 Enhances Panobinostat in Myeloma

  2026-08-13

  The reference study shows that the protein disulfide isomerase inhibitor LTI6426 markedly increases panobinostat activity in multiple myeloma models, including a proteasome inhibitor-resistant setting. Its central practical implication is that endoplasmic-reticulum stress may enable lower-dose panobinostat regimens, while ATF3, DDIT3/CHOP, and DNAJB1 emerge as candidate pharmacodynamic biomarkers.

• Phenacetin as a Translational PK Benchmark

  2026-08-13

  Phenacetin is more than a historical analgesic reference: its defined structure, limited water solubility, and safety constraints make it a useful stress test for translational pharmacokinetic workflows. This article connects Phenacetin assay strategy with the evidence architecture used in PDK4 inhibitor discovery, while clearly separating chemical benchmarking from target-specific pharmacology and clinical claims.

• LY364947: TGF-β Kinase Inhibition Workflows

  2026-08-12

  LY364947 provides a receptor-level way to dissect TGF-β signaling, Smad2 activation, EMT, fibrosis, and injury responses. This workflow-focused guide connects LY364947 with pancreatic cancer EMT research while emphasizing solvent handling, assay controls, quantitative readouts, and interpretation limits.

16098 records 1/1074 page Next 12345 下5页 Last page